​

Hinge Health (HNGE) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

HNGE Stock Forecast

Hinge Health (HNGE) stock forecast, based on 12 Wall Street analysts, predicts a 12-month average price target of $56.78, with a high of $68.00 and a low of $50.00. This represents a 71.80% increase from the last price of $33.05.

HNGE Stock Rating

Hinge Health stock's rating consensus is Buy, based on 12 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 12 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 12 0 12 Strong Sell Sell Hold Buy Strong Buy

HNGE Price Target Upside V Benchmarks

TypeNameUpside
StockHinge Health71.80%
SectorHealthcare Stocks 15.45%
IndustryHealthcare Information Services Stocks 48.24%

Price Target Trends

1M3M12M
# Anlaysts5919
Avg Price Target$53.40$58.33$56.32
Last Closing Price$33.05$33.05$33.05
Upside/Downside61.57%76.49%70.41%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 26791--17
Jan, 26771--15
Dec, 25771--15
Nov, 25771--15
Oct, 25771--15
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 11, 2026KeyBanc$55.00$37.6346.16%66.41%
Feb 11, 2026Rishi JaluriaRBC Capital$50.00$35.4141.20%51.29%
Feb 11, 2026Elizabeth AndersonEvercore ISI$50.00$37.8332.17%51.29%
Feb 11, 2026Canaccord Genuity$53.00$33.0560.36%60.36%
Feb 05, 2026Stifel Nicolaus$59.00$32.3282.55%78.52%
Jan 09, 2026Piper Sandler$60.00$49.4121.43%81.54%
Jan 08, 2026Stan BerenshteynWells Fargo$68.00$49.4137.62%105.75%
Jan 08, 2026KeyBanc$70.00$49.1442.45%111.80%
Jan 05, 2026Barclays$60.00$45.5631.69%81.54%
Nov 05, 2025Canaccord Genuity$65.00$46.3140.36%96.67%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 11, 2026RBC CapitalOutperformOutperformhold
Feb 11, 2026Evercore ISIOutperformOutperformhold
Jan 08, 2026Wells FargoOverweightinitialise
Nov 05, 2025Piper SandlerOverweightOverweighthold
Nov 05, 2025BarclaysOverweightOverweighthold
Oct 08, 2025Evercore ISIOutperformOutperformhold
Sep 23, 2025Morgan StanleyOverweightOverweighthold
Jul 14, 2025BarclaysOverweightOverweighthold
Jul 14, 2025CitigroupOutperforminitialise
Jun 16, 2025Piper SandlerOverweightinitialise

Financial Forecast

EPS Forecast

$-25 $-19 $-13 $-7 $-1 $5 Dec 24 Dec 25 Dec 26 Dec 27
Dec 24Dec 25Dec 26Dec 27
Reported----
Avg Forecast$-19.47$1.04$1.16$0.13
High Forecast$-18.84$1.27$1.39$0.58
Low Forecast$-20.16$0.55$0.76$-0.17
Surprise %----

Revenue Forecast

$350M $440M $530M $620M $710M $800M Dec 24 Dec 25 Dec 26 Dec 27
Dec 24Dec 25Dec 26Dec 27
Reported$390.40M---
Avg Forecast$480.79M$551.14M$650.51M$776.23M
High Forecast$493.85M$555.10M$671.40M$797.31M
Low Forecast$468.89M$549.00M$612.50M$757.01M
Surprise %-18.80%---

Net Income Forecast

$-2B $-2B $-1B $-500M $0 $500M Dec 24 Dec 25 Dec 26 Dec 27
Dec 24Dec 25Dec 26Dec 27
Reported$-11.93M---
Avg Forecast$-1.52B$70.99M$83.87M$21.00M
High Forecast$-1.47B$99.08M$108.44M$45.25M
Low Forecast$-1.57B$42.91M$59.29M$-13.26M
Surprise %-99.22%---

HNGE Forecast FAQ

Is Hinge Health stock a buy?

Hinge Health stock has a consensus rating of Buy, based on 12 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 12 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Hinge Health is a favorable investment for most analysts.

What is Hinge Health's price target?

Hinge Health's price target, set by 12 Wall Street analysts, averages $56.78 over the next 12 months. The price target range spans from $50 at the low end to $68 at the high end, suggesting a potential 71.80% change from the previous closing price of $33.05.

How does Hinge Health stock forecast compare to its benchmarks?

Hinge Health's stock forecast shows a 71.80% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the healthcare information services stocks industry (48.24%).

What is the breakdown of analyst ratings for Hinge Health over the past three months?

  • February 2026: 41.18% Strong Buy, 52.94% Buy, 5.88% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 46.67% Strong Buy, 46.67% Buy, 6.67% Hold, 0% Sell, 0% Strong Sell.
  • December 2025: 46.67% Strong Buy, 46.67% Buy, 6.67% Hold, 0% Sell, 0% Strong Sell.

What is Hinge Health’s EPS forecast?

Hinge Health's average annual EPS forecast for its fiscal year ending in December 2025 is $1.04, marking a 0% decrease from the reported $0 in 2024. Estimates for the following years are $1.16 in 2026, and $0.13 in 2027.

What is Hinge Health’s revenue forecast?

Hinge Health's average annual revenue forecast for its fiscal year ending in December 2025 is $551.14M, reflecting a 41.17% increase from the reported $390.4M in 2024. The forecast for 2026 is $650.51M, and $776.23M for 2027.

What is Hinge Health’s net income forecast?

Hinge Health's net income forecast for the fiscal year ending in December 2025 stands at $70.99M, representing a -694.94% decrease from the reported $-11.933M in 2024. Projections indicate $83.87M in 2026, and $21M in 2027.